BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.
Publication
, Conference
Peters, KB; Cohen, AL; Butowski, NA; Villano, JL; Giglio, P; McGranahan, T; Zhang, C; Cloughesy, TF; Herndon, JE; Healy, P; MacLeod, D; Gad, S ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K. B., Cohen, A. L., Butowski, N. A., Villano, J. L., Giglio, P., McGranahan, T., … Crapo, J. (2020). BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Peters, Katherine B., Adam Louis Cohen, Nicholas A. Butowski, John L. Villano, Pierre Giglio, Tresa McGranahan, Chi Zhang, et al. “BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Peters KB, Cohen AL, Butowski NA, Villano JL, Giglio P, McGranahan T, et al. BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Peters, Katherine B., et al. “BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.
Peters KB, Cohen AL, Butowski NA, Villano JL, Giglio P, McGranahan T, Zhang C, Cloughesy TF, Herndon JE, Healy P, MacLeod D, Penchev S, Silberstein D, Batinic-Haberle I, Spasojevic I, Gad S, Radoff D, Barboriak D, Crapo J. BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001. JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences